320 related articles for article (PubMed ID: 11426964)
1. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
2. Human epithelial ovarian cancer allelotype.
Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
[TBL] [Abstract][Full Text] [Related]
3. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.
Huang LW; Garrett AP; Schorge JO; Muto MG; Bell DA; Welch WR; Berkowitz RS; Mok SC
Am J Clin Pathol; 2000 Jul; 114(1):93-9. PubMed ID: 10884804
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
5. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
6. Allelotype of human ovarian cancer.
Sato T; Saito H; Morita R; Koi S; Lee JH; Nakamura Y
Cancer Res; 1991 Oct; 51(19):5118-22. PubMed ID: 1655245
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
8. Allelotype analysis of esophageal squamous cell carcinoma.
Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088
[TBL] [Abstract][Full Text] [Related]
9. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum.
Bandera CA; Muto MG; Welch WR; Berkowitz RS; Mok SC
Oncogene; 1998 Jul; 16(26):3455-9. PubMed ID: 9692553
[TBL] [Abstract][Full Text] [Related]
10. Allelotype analysis of childhood acute lymphoblastic leukemia.
Takeuchi S; Bartram CR; Wada M; Reiter A; Hatta Y; Seriu T; Lee E; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1995 Nov; 55(22):5377-82. PubMed ID: 7585604
[TBL] [Abstract][Full Text] [Related]
11. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
13. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
[TBL] [Abstract][Full Text] [Related]
14. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan.
Chao KC; Chen YJ; Juang CM; Lau HY; Wen KC; Sung PL; Fang FY; Twu NF; Yen MS
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):81-4. PubMed ID: 23548224
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
[TBL] [Abstract][Full Text] [Related]
18. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of clinical characteristics of extraovarian peritoneal serous papillary carcinoma with papillary serous ovarian carcinoma].
Peng YZ; Shen K; Wu M; Huang HF; Pan LY; Yang JX; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):243-5. PubMed ID: 15924670
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
